Real‐world use of dupilumab for 53 patients with atopic dermatitis in Japan
Author:
Affiliation:
1. Department of Dermatology Hyogo College of Medicine Nishinomiya Japan
2. Department of Ophthalmology Hyogo College of Medicine Nishinomiya Japan
Publisher
Wiley
Subject
Dermatology,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cia2.12099
Reference6 articles.
1. Real‐world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single‐centre retrospective study
2. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
3. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity
4. Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre
5. Conjunctivitis in dupilumab clinical trials
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-world efficacy of dupilumab re-administration after discontinuation in patients with atopic dermatitis;Journal of Cutaneous Immunology and Allergy;2024-01-22
2. Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study;Clinical Drug Investigation;2023-04
3. Safety and effectiveness of dupilumab in the real‐world treatment of atopic dermatitis in Japan: 1‐year interim analysis from a post‐marketing surveillance;Journal of Cutaneous Immunology and Allergy;2023-03-23
4. Immunodeficiency diseases that should be differentiated from atopic dermatitis;Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology;2022-12-20
5. Association study of transition of laboratory marker levels and transition of disease activity of atopic dermatitis patients treated with dupilumab;Australasian Journal of Dermatology;2021-09-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3